Cambridge, UK




Compiled by Jim Haseloff at the University of Cambridge.
This site contains details of recent papers and activity in Synthetic Biology, with particular emphasis on: (i) development of standards in biology and DNA parts, (ii) microbial and (iii) plant systems, (iv) hardware for scientific computing and instrumentation, (v) tools for scientific productivity and (vi) collected miscellany.
The site also contains details of Synthetic Biology research and teaching at the University of Cambridge, including the annual iGEM team run by Jim Ajioka, Jim Haseloff and Gos Micklem in Cambridge.
The Fourth International Workshop on Bio-Design Automation (IWBDA) at DAC will bring together researchers from the synthetic biology, systems biology, and design automation communities....
The overall goal for the workshop is to bring together scientists working in the highly interdisciplinary field of synthetic biology to present cutting-edge research aligned with three...
GCAT is pleased to announce a synthetic biology faculty workshop for the summer of 2012 (June 20-22) hosted by HHMI’s Science Education Alliance (SEA). The goal of this workshop...
A student and post-doc organised conference: they have invited the world's leading scientists to highlight the recent advances in microbial engineering, along with discussing the challenges...
A week long, professional development class will prepare educators to bring biological engineering and synthetic biology into their classrooms and laboratories. The workshop will include...
Finals for the international Genetically Engineered Machine Competition.
The 2nd CSH Asia Synthetic Biology meeting will be held at the Suzhou Dushu Lake Conference Center in Suzhou, China, located approximately 60 miles west of Shanghai.
(Re-)constructing and Re-programming Life

Monsanto has announced it will scrap plans to sell an insect-resistant maize in France, the second move in a week by biotech company to retreat from the genetically modified foods market in Europe.
Monsanto's announcement on Tuesday (24 January) came a week after Germany's BASF said it would suspend the development of GM crops in Europe and move its plant science arm to the United States. BASF's move is a particular blow for Europe, said Carel du Marchie Sarvaas, director of agricultural biotechnology at EuropaBio.
"The BASF decision is not good for Europe because I think it is the reaction of a quintessentially European company to what is a stifling political and regulatory environment,” said du Marchie Sarvaas, whose Brussels organisation represents agricultural technology companies.
“Research, jobs, money will go to where it is welcomed. In this case it will be somewhere else. It's a bad day for Europe."
Monsanto said it would not resume sales of MON810, a maize genetically modified to improve pest resistance, despite a French court ruling in November that overturned a 2008 government ban on the sale of MON810. “Monsanto considers that favourable conditions for the sale of the MON810 in France in 2012 and beyond are not in place,” the St. Louis, Missouri-based company said in a statement.
'Lack of acceptance'
BASF’s decision to move its plant science headquarters from Limburgerhof, Germany, to Raleigh, North Carolina was an acknowledgement that GM plants are unpopular in the European Union. “We are convinced that plant biotechnology is a key technology for the 21st century,” Stefan Marcinowski, a board member of BASF in charge of plant biotechnology, said in a statement on 16 January. “However, there is still a lack of acceptance for this technology in many parts of Europe – from the majority of consumers, farmers and politicians.
“Therefore, it does not make business sense to continue investing in products exclusively for cultivation in this market.” While widely accepted on the other side of the Atlantic, GM crops have long been a volatile issue in Europe. Public opinion surveys conducted by Eurobarometer and other polling agencies show a high level if distrust in GM crops in the EU. Environmental and consumer groups have pressed for restrictions on imports of GM seeds and crops. Adrian Bebb, food campaigner for Friends of the Earth Europe, welcomed the BASF decision last week.
“This is another nail in the coffin for genetically modified foods in Europe,” Bebb said. “No one wants to eat them and few farmers want to grow them. This is a good day for consumers and farmers and opens the door for the European Union to shift Europe to greener and more publicly acceptable farming."
In November, Greens in the European Parliament urged the European Commission to rethink its trade ties with Latin American nations that grow a large part of the protein plants used in animal feed in Europe, arguing that many of the imports are produced through genetically modified crops and are therefore making their way into the food chain. Still, the opposition is not universal. Last year, MEPs voted overwhelmingly in support of plans to let national governments choose whether to ban the cultivation of GM crops on their territory amid resistance from some countries – including the Czech Republic and Spain – to EU-wide restrictions.
from: http://www.euractiv.com/cap/disgruntled-gmo-firms-start-pulling-eu-market-news-510378